Hepatitis C virus genotype 5: prospective evaluation of peginterferon/ribavirin treatment efficacy and predictive value of on-treatment virological responses for sustained virological response.

Abstract excerpt

GOALS: To examine the treatment efficacy of a combination of pegylated interferon α (PegIFNa) plus ribavirin in patients chronically infected with hepatitis C virus genotype 5 (HCV-5) and to assess the on-treatment virological responses as predictors of sustained virological response (SVR). BACKGROUND: HCV-5 is uncommonly reported, and little therapeutic data is available regarding previous retrospective studies...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alanine Transaminase
• Share to Drug Therapy, Combination